What Are Human Enhancement Technologies?

Human enhancement technologies are biomedical, pharmacological, genetic, and engineering interventions applied to improve human physical, cognitive, or sensory capabilities beyond what is required to restore normal healthy function. The category is distinguished from therapeutic medicine by its goal: where therapy targets a diagnosed condition, enhancement targets performance in a healthy individual. This boundary, while conceptually clear, is difficult to maintain in practice because the same drug, device, or genetic modification may function as therapy in one person and enhancement in another. Technologies in this space are studied across biomedical engineering, neuroscience, genetics, and pharmaceutical science, with strong parallel research in ethics and regulatory policy.

The PMC review of human enhancement and bioethical implications frames the field around three principal categories: genetic modification, pharmacological agents, and cybernetic or bioelectronic augmentation. Each category operates on different biological substrates, targets different timescales of effect, and carries its own safety and governance challenges.

Bioelectronic and Neural Enhancement

Bioelectronic enhancement technologies interact with the nervous system through electrical or electromagnetic signals. Deep brain stimulation, approved for Parkinson's disease and treatment-resistant depression, is also being explored for cognitive enhancement in healthy subjects. Non-invasive brain stimulation techniques, including transcranial direct-current stimulation (tDCS) and transcranial magnetic stimulation (TMS), modulate cortical excitability and have been studied for effects on working memory, attention, and motor learning.

Neural interfaces, the most invasive category, record from and write into neural circuits directly. Brain-computer interface research at academic and commercial centers targets motor and sensory restoration, but the underlying technologies are also capable of augmenting function in healthy users. The regulatory and safety pathway for these devices is governed in the United States by the FDA under Class III medical device rules, regardless of whether the intended use is therapeutic or enhancement.

Pharmacological Enhancement

Pharmacological agents used for enhancement include stimulants, nootropics, and modafinil-class wakefulness-promoting drugs. Modafinil, approved for narcolepsy and shift-work sleep disorder, is widely used off-label by students and professionals to sustain alertness and attention across long work periods. Methylphenidate and amphetamine salts, approved for attention-deficit/hyperactivity disorder, are similarly used without a diagnosis. The PMC overview of pharmacological human enhancement identifies dose-response uncertainty, long-term safety data gaps, and context dependence as the primary scientific concerns, while regulatory frameworks in most jurisdictions have not been updated to address enhancement use specifically.

Growth hormone and erythropoietin (EPO) represent enhancement in athletic contexts; both are detected and prohibited by the World Anti-Doping Agency, whose policies inform broader governance discussions about performance-enhancing pharmacology.

Genetic and Biological Enhancement

Genetic enhancement uses tools such as CRISPR-Cas9 genome editing to modify heritable or somatic DNA to improve function. Somatic gene modification affects only the treated individual, while germline modification, altering embryos or gametes, would be heritable. The PMC analysis of genetic engineering and human enhancement notes that germline modification for enhancement purposes is currently prohibited in most jurisdictions following widespread scientific consensus that the risk-benefit profile is inadequately understood.

Synthetic biology approaches to enhancement include engineered microbiomes, exogenous metabolic pathways, and cell therapies designed to exceed natural metabolic or immune performance. These approaches are largely in early research phases and have not progressed to human trials outside therapeutic contexts.

Applications

Human enhancement technologies have applications in a wide range of fields, including:

• Military operational performance improvement for sustained attention and physical endurance
• Elite athletic training and recovery optimization
• Occupational performance support in high-demand professions such as surgery and aviation
• Age-related decline mitigation in healthy older adults
• Space exploration physiology, where environmental extremes demand enhanced human capacity